Literature DB >> 845988

Secular trends of cerebellar gliomas in children.

A Fulchiero, K Winston, A Leviton, F H Gilles.   

Abstract

Temporal changes in the histologic composition of cerebellar gliomas were examined in a population of 132 children operated on between 1927 and 1968 at The Children's Hospital Medical Center of Boston. Linear trends with time were examined for clinical features, histologic features, and tumor types. We found evidence of an increasing occurrence of glioma A and its associated features during the 41-year study period. This tumor type is associated with a good prognosis and is histologically well defined. Glioma B, a tumor type associated with a poor prognosis, was relatively stable with respect to time and, therefore, differed markedly from glioma A. Foci of oligodendroglia, a glioma A feature, clustered by year of surgery within a relatively short time span. This feature had a survival rate and a male sex proportion quite different from those of the other histologic features investigated.

Entities:  

Mesh:

Year:  1977        PMID: 845988     DOI: 10.1093/jnci/58.4.839

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  Cerebellar astrocytomas. Clinical characteristics and prognostic indices.

Authors:  E B Ilgren; C A Stiller
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 2.  Cerebellar astrocytomas in children.

Authors:  J W Campbell; I F Pollack
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 3.  Temporal trends among childhood brain tumor biopsies. The Childhood Brain Tumor Consortium.

Authors:  F H Gilles; E L Sobel; A Leviton; E T Hedley-Whyte; C J Tavare; L Adelman; R A Sobel
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

4.  Cerebellar astrocytomas in children and young adults.

Authors:  C H Davis; V M Joglekar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.